BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
SNCA
,
Fatty acid metabolic process
,
Leukemia
,
Stem cell
,
Neocentromeres
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
negative regulation of histone methylation
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Tonsil
Thymus gland
Heart
Frontal cortex
Spleen
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Tularemia
Pyloric ulcer
Shock
Hemorrhagic shock
Bacterial septicemia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
ALW-II-49-7
benz(a)anthracene
PHA 793887
ARQ 197
AT 7519
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Ptger4
CCDC170
NCL
FADD
TBC1D23
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
A single cell analysis of developing germ cells during mouse sex determination
A single cell analysis of normal human lung
GSK cancer cell line transcript profiling
Nasal epithelium from maxilloturbinate region of Cynomolgus macaques
L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for negative regulation of histone methylation
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Fetal Exposure to Cannabinoids: Exposure, Methylation and Neurodevelopmental Effects
Epigenetic Regulation of BDNF in Schizophrenia
Family Resilience Initiative Research Program
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ